Skip to main content
NCBI home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2001 Nov;85(3):F207–F213. doi: 10.1136/fn.85.3.F207

Nephrocalcinosis in preterm babies

A Narendra, M White, H Rolton, Z Alloub, G Wilkinson, J McColl, J Beattie
PMCID: PMC1721318  PMID: 11668166

Abstract

OBJECTIVES—To determine prospectively the incidence and cause of nephrocalcinosis in preterm infants.
STUDY DESIGN—Inborn babies of gestation less than 32 weeks or birth weight less than 1500 g were eligible to be entered into a prospective observational study. Two renal ultrasound scans were performed, the first at 1 month postnatal age and the second at term or discharge. Data were collected on gestation, birth weight, sex, race, family history of renal calculi, oliguria on first day, respiratory support (ventilation, steroid, and oxygen dependency), and use of nephrotoxic drugs (gentamicin, vancomycin, and frusemide). Intake of fluid, calcium, and phosphate and plasma urea, creatinine, calcium, and phosphate were recorded for the first 6 weeks of life. Random urinary calcium/creatinine, oxalate/creatinine, and urate/creatinine ratios and tubular absorption of phosphate were measured once at term.
RESULTS—A total of 101 preterm infants were studied. Twenty three (23%) had abnormal ultrasound scans. Sixteen (16%) had nephrocalcinosis. On univariate analysis, gestational age, male sex, duration of ventilation, oxygen dependency, duration and frequency of gentamicin treatment, toxic gentamicin/vancomycin levels, and postnatal dexamethasone were significantly associated with nephrocalcinosis. In addition, babies with nephrocalcinosis had a lower intake of fluid, calcium, and phosphate, longer duration of total parenteral nutrition, and higher urinary oxalate/creatinine and urate/creatinine ratios than infants who did not have the condition. There was also a significant association with plasma urea and creatinine but not with plasma calcium or phosphate or urinary calcium. Multivariate analysis showed that the strongest predictors of nephrocalcinosis were duration of ventilation, toxic gentamicin/vancomycin levels, low fluid intake, and male sex.
CONCLUSION—16% of babies born at less than 32 weeks gestation developed nephrocalcinosis. The multifactorial origin, in particular, the association with extreme prematurity and severity of respiratory disease, is confirmed. In addition, an association with male sex, frequency and duration of gentamicin use, and high urinary oxalate and urate excretion is shown.



Full Text

The Full Text of this article is available as a PDF (146.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams N. D., Rowe J. C. Nephrocalcinosis. Clin Perinatol. 1992 Mar;19(1):179–195. [PubMed] [Google Scholar]
  2. Andronikou S., Giapros V. I., Cholevas V. I., Papadopoulou Z. L. Effect of aminoglycoside therapy on renal function in full-term infants. Pediatr Nephrol. 1996 Dec;10(6):766–768. doi: 10.1007/s004670050214. [DOI] [PubMed] [Google Scholar]
  3. Barcelo P., Wuhl O., Servitge E., Rousaud A., Pak C. Y. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol. 1993 Dec;150(6):1761–1764. doi: 10.1016/s0022-5347(17)35888-3. [DOI] [PubMed] [Google Scholar]
  4. Bennett W. M., Plamp C. E., Gilbert D. N., Parker R. A., Porter G. A. The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J Infect Dis. 1979 Oct;140(4):576–580. doi: 10.1093/infdis/140.4.576. [DOI] [PubMed] [Google Scholar]
  5. Bérard E., Dageville C., Bekri S., Boutté P., Coussement A., Mariani R. Nephrocalcinosis and prematurity: importance of urate and oxalate excretion. Nephron. 1995;69(3):237–241. doi: 10.1159/000188463. [DOI] [PubMed] [Google Scholar]
  6. Campfield T., Braden G., Flynn-Valone P., Clark N. Urinary oxalate excretion in premature infants: effect of human milk versus formula feeding. Pediatrics. 1994 Nov;94(5):674–678. [PubMed] [Google Scholar]
  7. Campfield T., Braden G. Urinary oxalate excretion by very low birth weight infants receiving parenteral nutrition. Pediatrics. 1989 Nov;84(5):860–863. [PubMed] [Google Scholar]
  8. Coe F. L. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med. 1977 Oct;87(4):404–410. doi: 10.7326/0003-4819-87-4-404. [DOI] [PubMed] [Google Scholar]
  9. Cramer B., Husa L., Pushpanathan C. Nephrocalcinosis in rabbits--correlation of ultrasound, computed tomography, pathology and renal function. Pediatr Radiol. 1998 Jan;28(1):9–13. doi: 10.1007/s002470050283. [DOI] [PubMed] [Google Scholar]
  10. Downing G. J., Egelhoff J. C., Daily D. K., Alon U. Furosemide-related renal calcifications in the premature infant. A longitudinal ultrasonographic study. Pediatr Radiol. 1991;21(8):563–565. doi: 10.1007/BF02012598. [DOI] [PubMed] [Google Scholar]
  11. Downing G. J., Egelhoff J. C., Daily D. K., Thomas M. K., Alon U. Kidney function in very low birth weight infants with furosemide-related renal calcifications at ages 1 to 2 years. J Pediatr. 1992 Apr;120(4 Pt 1):599–604. doi: 10.1016/s0022-3476(05)82490-4. [DOI] [PubMed] [Google Scholar]
  12. Ettinger B., Pak C. Y., Citron J. T., Thomas C., Adams-Huet B., Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997 Dec;158(6):2069–2073. doi: 10.1016/s0022-5347(01)68155-2. [DOI] [PubMed] [Google Scholar]
  13. Ezzedeen F., Adelman R. D., Ahlfors C. E. Renal calcification in preterm infants: pathophysiology and long-term sequelae. J Pediatr. 1988 Sep;113(3):532–539. doi: 10.1016/s0022-3476(88)80647-4. [DOI] [PubMed] [Google Scholar]
  14. Fauconneau B., Favrelière S., Pariat C., Génévrier A., Courtois P., Piriou A., Bouquet S. Nephrotoxicity of gentamicin and vancomycin given alone and in combination as determined by enzymuria and cortical antibiotic levels in rats. Ren Fail. 1997 Jan;19(1):15–22. doi: 10.3109/08860229709026256. [DOI] [PubMed] [Google Scholar]
  15. Frame P. T., Phair J. P., Watanakunakorn C., Bannister T. W. Pharmacologic factors associated with gentamicin nephrotoxicity in rabbits. J Infect Dis. 1977 Jun;135(6):952–956. doi: 10.1093/infdis/135.6.952. [DOI] [PubMed] [Google Scholar]
  16. Holland P. C., Wilkinson A. R., Diez J., Lindsell D. R. Prenatal deficiency of phosphate, phosphate supplementation, and rickets in very-low-birthweight infants. Lancet. 1990 Mar 24;335(8691):697–701. doi: 10.1016/0140-6736(90)90810-r. [DOI] [PubMed] [Google Scholar]
  17. Hoppe B., Hesse A., Neuhaus T., Fanconi S., Blau N., Roth B., Leumann E. Influence of nutrition on urinary oxalate and calcium in preterm and term infants. Pediatr Nephrol. 1997 Dec;11(6):687–690. doi: 10.1007/s004670050366. [DOI] [PubMed] [Google Scholar]
  18. Hoppe B., Hesse A., Neuhaus T., Fanconi S., Forster I., Blau N., Leumann E. Urinary saturation and nephrocalcinosis in preterm infants: effect of parenteral nutrition. Arch Dis Child. 1993 Sep;69(3 Spec No):299–303. doi: 10.1136/adc.69.3_spec_no.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hufnagle K. G., Khan S. N., Penn D., Cacciarelli A., Williams P. Renal calcifications: a complication of long-term furosemide therapy in preterm infants. Pediatrics. 1982 Sep;70(3):360–363. [PubMed] [Google Scholar]
  20. Jacinto J. S., Modanlou H. D., Crade M., Strauss A. A., Bosu S. K. Renal calcification incidence in very low birth weight infants. Pediatrics. 1988 Jan;81(1):31–35. [PubMed] [Google Scholar]
  21. Jones C. A., King S., Shaw N. J., Judd B. A. Renal calcification in preterm infants: follow up at 4-5 years. Arch Dis Child Fetal Neonatal Ed. 1997 May;76(3):F185–F189. doi: 10.1136/fn.76.3.f185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Karlowicz M. G., Katz M. E., Adelman R. D., Solhaug M. J. Nephrocalcinosis in very low birth weight neonates: family history of kidney stones and ethnicity as independent risk factors. J Pediatr. 1993 Apr;122(4):635–638. doi: 10.1016/s0022-3476(05)83553-x. [DOI] [PubMed] [Google Scholar]
  23. Katz M. E., Karlowicz M. G., Adelman R. D., Werner A. L., Solhaug M. J. Nephrocalcinosis in very low birth weight neonates: sonographic patterns, histologic characteristics, and clinical risk factors. J Ultrasound Med. 1994 Oct;13(10):777–782. doi: 10.7863/jum.1994.13.10.777. [DOI] [PubMed] [Google Scholar]
  24. Leumann E. P., Dietl A., Matasovic A. Urinary oxalate and glycolate excretion in healthy infants and children. Pediatr Nephrol. 1990 Sep;4(5):493–497. doi: 10.1007/BF00869828. [DOI] [PubMed] [Google Scholar]
  25. Matsuzaki H., Uehara M., Suzuki K., Liu Q. L., Sato S., Kanke Y., Goto S. High phosphorus diet rapidly induces nephrocalcinosis and proximal tubular injury in rats. J Nutr Sci Vitaminol (Tokyo) 1997 Dec;43(6):627–641. doi: 10.3177/jnsv.43.627. [DOI] [PubMed] [Google Scholar]
  26. McCormick F. C., Brady K., Keen C. E. Oxalate nephrocalcinosis: a study in autopsied infants and neonates. Pediatr Pathol Lab Med. 1996 May-Jun;16(3):479–488. doi: 10.1080/15513819609168685. [DOI] [PubMed] [Google Scholar]
  27. Modanlou H. D., Beharry K., Padilla G., Iriye B. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants. J Perinatol. 1996 Nov-Dec;16(6):422–430. [PubMed] [Google Scholar]
  28. Murphy J. L., Mendoza S. A. Decreased urinary citrate in premature infants with lung disease. Child Nephrol Urol. 1990;10(2):76–80. [PubMed] [Google Scholar]
  29. Myracle M. R., McGahan J. P., Goetzman B. W., Adelman R. D. Ultrasound diagnosis of renal calcification in infants on chronic furosemide therapy. J Clin Ultrasound. 1986 May;14(4):281–287. doi: 10.1002/jcu.1870140408. [DOI] [PubMed] [Google Scholar]
  30. Osorio A. V., Alon M. M., Nichols M. A., Alon U. S. Effect of age on furosemide-induced nephrocalcinosis in the rat. Biol Neonate. 1998;73(5):306–312. doi: 10.1159/000013989. [DOI] [PubMed] [Google Scholar]
  31. Parsons P. P., Garland H. O., Harpur E. S., Old S. Acute gentamicin-induced hypercalciuria and hypermagnesiuria in the rat: dose-response relationship and role of renal tubular injury. Br J Pharmacol. 1997 Oct;122(3):570–576. doi: 10.1038/sj.bjp.0701403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pope J. C., 4th, Trusler L. A., Klein A. M., Walsh W. F., Yared A., Brock J. W., 3rd The natural history of nephrocalcinosis in premature infants treated with loop diuretics. J Urol. 1996 Aug;156(2 Pt 2):709–712. doi: 10.1097/00005392-199608001-00039. [DOI] [PubMed] [Google Scholar]
  33. Reusz G. S., Dobos M., Byrd D., Sallay P., Miltényi M., Tulassay T. Urinary calcium and oxalate excretion in children. Pediatr Nephrol. 1995 Feb;9(1):39–44. doi: 10.1007/BF00858966. [DOI] [PubMed] [Google Scholar]
  34. Robertson W. G., Peacock M. The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron. 1980;26(3):105–110. doi: 10.1159/000181963. [DOI] [PubMed] [Google Scholar]
  35. Saarela T., Vaarala A., Lanning P., Koivisto M. Incidence, ultrasonic patterns and resolution of nephrocalcinosis in very low birthweight infants. Acta Paediatr. 1999 Jun;88(6):655–660. doi: 10.1080/08035259950169332. [DOI] [PubMed] [Google Scholar]
  36. Short A., Cooke R. W. The incidence of renal calcification in preterm infants. Arch Dis Child. 1991 Apr;66(4 Spec No):412–417. doi: 10.1136/adc.66.4_spec_no.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Short A., Shaw N. J., Weindling A. M. Nephrocalcinosis and phosphate supplementation in a preterm infant. Acta Paediatr Scand. 1990 Oct;79(10):968–969. doi: 10.1111/j.1651-2227.1990.tb11362.x. [DOI] [PubMed] [Google Scholar]
  38. Sonntag J., Gaude M. Einfluss einer Dexamethason- und Spironolactontherapie auf den Kalzium- und Phosphathaushalt bei Frühgeborenen mit einem Geburtsgewicht unter 1500 g. Klin Padiatr. 1998 Sep-Oct;210(5):354–357. doi: 10.1055/s-2008-1043902. [DOI] [PubMed] [Google Scholar]
  39. Sonntag J., Schaub J. Oxalate excretion during the first 7 weeks in very-low-birth-weight infants. Biol Neonate. 1997;71(5):277–281. doi: 10.1159/000244426. [DOI] [PubMed] [Google Scholar]
  40. Stapleton F. B., McKay C. P., Noe H. N. Urolithiasis in children: the role of hypercalciuria. Pediatr Ann. 1987 Dec;16(12):980-1,984-92. doi: 10.3928/0090-4481-19871201-09. [DOI] [PubMed] [Google Scholar]
  41. Tsukahara H., Hiraoka M., Hori C., Tsuchida S., Uchida H., Fujisawa K., Konishi Y., Sudo M. Urinary uric acid excretion in term and premature infants. J Paediatr Child Health. 1996 Aug;32(4):330–332. doi: 10.1111/j.1440-1754.1996.tb02564.x. [DOI] [PubMed] [Google Scholar]
  42. Vileisis R. A. Effect of phosphorus intake in total parenteral nutrition infusates in premature neonates. J Pediatr. 1987 Apr;110(4):586–590. doi: 10.1016/s0022-3476(87)80558-9. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES